BURLINGTON, Mass., Feb. 24, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three upcoming investor conferences. The first is the Cowen and Company Healthcare Conference at the Boston Marriott Copley Place in Boston, MA, on Monday, March 3, 2014. The second is the ROTH Conference at The Ritz-Carlton, Laguna Niguel in Dana Point, CA, on Monday, March 10, 2014. The third is the BTIG Medical Technology, Diagnostics, and Healthcare IT Conference at The Cliff Lodge in Snowbird, UT, on Tuesday, March 18, 2014. Management will provide an update on the Company at all three conferences.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at http://www.lemaitre.com.
LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. Mary Nielson +1-781-425-1659 http://www.lemaitre.com
LeMaitre Vascular, Inc.
Burlington, Massachusetts, UNITED STATES
Day's Range: 7.88-8.24
Previous Close: 8.09
Market Cap: 124.77M
Day's Volume: 9,374
LeMaitre Vascular, Inc. Logo